Cargando…

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales

BACKGROUND: Seeking potentially novel blood markers of liver fibrosis and steatosis is constantly of crucial importance. Despite a growing number of studies in this field of hepatology, a certain role of hematological indices in the course of liver disorders has not been fully elucidated, yet. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalak, Agata, Cichoż-Lach, Halina, Guz, Małgorzata, Kozicka, Joanna, Cybulski, Marek, Jeleniewicz, Witold, Stepulak, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754555/ https://www.ncbi.nlm.nih.gov/pubmed/33384553 http://dx.doi.org/10.3748/wjg.v26.i47.7538

Ejemplares similares

Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients
por: Michalak, Agata, et al.
Publicado: (2021)

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
por: Michalak, Agata, et al.
Publicado: (2022)

Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients
por: Guz, Małgorzata, et al.
Publicado: (2020)

A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis
por: Cichoż-Lach, Halina, et al.
Publicado: (2017)

Liver injury in the era of COVID-19
por: Cichoż-Lach, Halina, et al.
Publicado: (2021)

Oxidative Stress—A Key Player in the Course of Alcohol-Related Liver Disease
por: Michalak, Agata, et al.
Publicado: (2021)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
por: Guz, Małgorzata, et al.
Publicado: (2021)

An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential
por: Guz, Małgorzata, et al.
Publicado: (2022)

Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy
por: Guz, Małgorzata, et al.
Publicado: (2023)

Dexmedetomidine Increases MMP-12 and MBP Concentrations after Coronary Artery Bypass Graft Surgery with Extracorporeal Circulation Anaesthesia without Impacting Cognitive Function: A Randomised Control Trial
por: Kowalczyk, Michał, et al.
Publicado: (2022)

Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review
por: Michalak, Agata, et al.
Publicado: (2022)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
por: Delicce, Michael, et al.
Publicado: (2022)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

Gender-related disparities in the frequencies of PD-1 and PD-L1 positive peripheral blood T and B lymphocytes in patients with alcohol-related liver disease: a single center pilot study
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2021)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Prognosis in Cirrhosis of the Liver
Publicado: (1892)

Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study
por: Tsai, Ming-Chang, et al.
Publicado: (2018)

Angiogenesis-Related Biomarkers in Patients with Alcoholic Liver Disease: Their Association with Liver Disease Complications and Outcome
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2014)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

A rare case of skin blistering and esophageal stenosis in the course of epidermolysis bullosa - case report and literature review
por: Michalak, Agata, et al.
Publicado: (2018)

Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
por: Xu, Nan, et al.
Publicado: (2020)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
por: Hoffmann, Peter, et al.
Publicado: (2020)

Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
por: Alkhouri, Naim, et al.
Publicado: (2022)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching
por: Cichoż-Lach, Halina, et al.
Publicado: (2018)

Blood concentrations of mediators released from activated neutrophils are related to the severity of alcohol-induced liver damage
por: Kasztelan-Szczerbinska, Beata, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
por: Skladany, Lubomir, et al.
Publicado: (2021)

Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis
por: Yang, Jun, et al.
Publicado: (2016)

Standards of liver cirrhosis care in Central Australia
por: Raja, Sreecanth S, et al.
Publicado: (2022)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74flb6apj1gmtnvm7gg04i19dl